News & Events about Incyte Corporation.
Incyte Co. (NASDAQ:INCY Get Rating) EVP Steven H. Stein sold 28,399 shares of Incyte stock in a transaction on Wednesday, January 4th. The stock was sold at an average price of $79.78, for a total transaction of $2,265,672.22. Following the sale, the executive vice president now directly ...
Incyte Co. (NASDAQ:INCY Get Rating) EVP Vijay K. Iyengar sold 17,324 shares of the stock in a transaction that occurred on Friday, December 23rd. The stock was sold at an average price of $80.80, for a total value of $1,399,779.20. Following the sale, the executive vice president now directly owns ...
Shares of Incyte Co. (NASDAQ:INCY Get Rating) have been assigned a consensus recommendation of Hold from the twelve research firms that are covering the stock, MarketBeat Ratings reports. One analyst has rated the stock with a sell recommendation, five have given a hold ...
Incyte Co. (NASDAQ:INCY Get Rating) has been given an average rating of Hold by the twelve ratings firms that are presently covering the firm, Marketbeat reports. One research analyst has rated the stock with a sell rating, five have assigned a hold rating and three have assigned a buy rating to the...
Incyte (NASDAQ:INCY) and CMS Aesthetics, a dermatology medical aesthetic company and subsidiary of CMS (HKEX: 00867), today announced that the companies have entered into a Collaboration and License Agreement for the development and commercialization of ruxolitinib cream, a novel cream formulation...